The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis.


Karadag-Saygi E., Akyuz G., Bizargity P., Ay P.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, cilt.27, sa.12, ss.1033-6, 2011 (SCI-Expanded) identifier identifier identifier

Özet

Background. To evaluate the effect of risedronate treatment on osteoprotegerin (OPG), C-terminal cross-linking telopeptide of type 1 collagen (CTX), osteocalcin (OC), and deoxypyridinoline (DPD).